Companies: 10,795·Total market cap: $144.5T
Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCENASDAQHealthcare● Active
$2.39
+$0.09(+3.91%)
Market Cap$36982860
P/E Ratio
52W High$5.18
52W Low$1.79
Overview

Grace Therapeutics, Inc.(GRCE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GRCE · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-032024-032023-032022-032021-03
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)61.22%
Operating Expenses
R&D Expenses$0.01B$0.01B$0.01B$0.01B$0.01B
G&A Expenses$0.01B$0.01B$0.01B$0.01B$0.01B
Total Operating Expenses$0.02B$0.02B$0.07B$0.02B$0.03B
Operating Income($0.02B)($0.02B)($0.07B)($0.02B)($0.03B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.02B)($0.02B)($0.07B)($0.01B)($0.03B)
Income Tax Expense($0.00B)($0.00B)($0.01B)($0.00B)$0.00B
Net Income($0.01B)($0.02B)($0.06B)($0.01B)($0.03B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.13$-1.83$-7.72$-2.02$-12.59
Wtd Avg Shares0.01B0.01B0.01B0.01B0.00B
EBITDA($0.02B)($0.02B)($0.02B)($0.02B)($0.02B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Grace Therapeutics, Inc.

关于Grace Therapeutics, Inc.(GRCE)损益表

Grace Therapeutics, Inc.(GRCE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GRCE实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.01B)(净利率—)。

常见问题

GRCE · 4 问

Grace Therapeutics, Inc.(GRCE)2025财年营收为$0.00B,同比down—%。

GRCE revenueGRCE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09